Patients had the device implanted subcutaneously over the tibial nerve using local anesthesia, with automatic treatments being delivered daily for 30 minutes. Patients completed 3 day bladder diaries at baseline, 4, 8 and 12 weeks. The Incontinence Quality of Life instrument was used to assess patients as well.
15 patients have completed the 4 week follow up. The authors found that so far, there is a 75% reduction in urge incontinence episodes per day. 5 patients have completed two months of follow up, with an 85% reduction in urge incontinence episodes per day. At 4 weeks, 69% of patients had iQoL score improvements greater than 10; 80% of patients had iQoL score improvements >10 at 2 months. No adverse events have been reported to date.
The preliminary data in a small sample size shows promise for the efficacy of the implantable eCoin™ system for tibial nerve stimulation. The authors admit that ongoing research and analysis of their full cohort will strengthen the data and conclusions made about this new technology.
Presented by: Scott A. MacDiarmid, MD, Alliance Urology Specialists
Co-Authors: Sharon English , Bilal Kaaki , Vince Lucente , Matthew Clark , Peter Gilling , Patrick Meffan and Peter Sand, Alliance Urology Specialists
Written by: Cristina Palmer, DO. Female Urology, Pelvic Reconstruction, Voiding Dysfunction Fellow, Department of Urology, UC Irvine Medical Center, Orange, California at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting (SUFU 2018), February 27-March 3, 2018, Austin, Texas